Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS

BACKGROUND: We tested the hypothesis that moxifloxacin monotherapy is equally effective and safe as a betalactam antibiotic based combination therapy in patients with acute respiratory distress syndrome (ARDS) evoked by severe community acquired pneumonia (CAP). METHODS: In a retrospective chart rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmel, Tim, Asmussen, Sven, Karlik, Jan, Steinmann, Jörg, Adamzik, Michael, Peters, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471686/
https://www.ncbi.nlm.nih.gov/pubmed/28615012
http://dx.doi.org/10.1186/s12871-017-0376-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471686/
https://www.ncbi.nlm.nih.gov/pubmed/28615012
http://dx.doi.org/10.1186/s12871-017-0376-5

Ejemplares similares